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The effect of high-fat diet on rat’s mood, feeding behavior and
response to stress
S Aslani1,2, N Vieira1,2, F Marques1,2, PS Costa1,2, N Sousa1,2 and JA Palha1,2
An association between obesity and depression has been indicated in studies addressing common physical (metabolic) and
psychological (anxiety, low self-esteem) outcomes. Of consideration in both obesity and depression are chronic mild stressors to
which individuals are exposed to on a daily basis. However, the response to stress is remarkably variable depending on numerous
factors, such as the physical health and the mental state at the time of exposure. Here a chronic mild stress (CMS) protocol was used
to assess the effect of high-fat diet (HFD)-induced obesity on response to stress in a rat model. In addition to the development of
metabolic complications, such as glucose intolerance, diet-induced obesity caused behavioral alterations. Speciﬁcally, animals fed
on HFD displayed depressive- and anxious-like behaviors that were only present in the normal diet (ND) group upon exposure to
CMS. Of notice, these mood impairments were not further aggravated when the HFD animals were exposed to CMS, which suggest
a ceiling effect. Moreover, although there was a sudden drop of food consumption in the ﬁrst 3 weeks of the CMS protocol in both
ND and HFD groups, only the CMS-HFD displayed an overall noticeable decrease in total food intake during the 6 weeks of the CMS
protocol. Altogether, the study suggests that HFD impacts on the response to CMS, which should be considered when addressing
the consequences of obesity in behavior.
Translational Psychiatry (2015) 5, e684; doi:10.1038/tp.2015.178; published online 24 November 2015
INTRODUCTION
Obesity is one of the main health concerns in today’s society.1 It is
mainly described as an excessive increase in body weight, with
disproportionate accumulation of body fat mass, caused by excess
energy intake over energy expenditure over a long period of
time.1,2 Besides the well-recognized set of metabolic alterations,
obesity is also suggested to be associated with psychiatric
disorders, such as anxiety and depression2 (albeit not all studies
show such association).3–5 Depression in itself is a serious chronic
mental disorder characterized by health complications including,
among others, anhedonia and changes in appetite and pattern of
food intake.6–9 Mild environmental stressors, to which individuals
are exposed daily, can be both triggers of depression and alter
feeding behaviors.1,2 Thus, these may, directly or indirectly,
contribute to the metabolic changes triggered by elevated
glucocorticoids, as well as to the onset of obesity.1,10,11 However,
it is interesting to note that the individual’s response to stress
depends on various factors, including the type of stressors, their
intensity, frequency and duration.12 In fact, the individual
speciﬁcities in the stress response, namely in terms of metabolism,
may explain some of the controversies in the literature. Studies in
animal models of stress showed that while intense and painful
stressors result in inhibition of food intake,12 and exposure to
chronic mild stressors leads to a reduction in food intake,1,2,12,13
other mild stressors induce spontaneous feeding.1 Still, most of
the studies have focused on the acute effect of stress on animals’
feeding behavior and are mostly conducted using healthy animals
displaying normal body weight and fed with regular rodent diet.
Therefore, information is lacking on the effects of stress in animal
models under other types of diets, namely high-fat diet (HFD).
Here we used a model of HFD-induced obesity to evaluate the
consequences of HFD on mood and cognition and on the animals’
ability to respond to chronic mild stress (CMS).
MATERIALS AND METHODS
Animals and diets
Animals were housed under standard laboratory conditions (two rats per
cage; room temperature 22 °C and humidity of 55%; light change every
12 h with lights on at 0800 hours; food and water ad libitum). All animals
were used in accordance with European Union regulations (Directive
86/609/EEC); and the experimental protocol was approved by the national
competent authority, Direção-Geral de Alimentação e Vererinária (DGAV).
Male offspring from eight pregnant Wistar Han rats (Charles-River
Laboratories, Barcelona, Spain) were separated from their mothers at the
age of 3 weeks and randomly divided in two groups with different diets: (i)
normal rat laboratory chow (normal diet (ND), total 2.67 kcal g− 1—
carbohydrate 53.5%, fat 3% and protein 18.5%; diet #4RF21-GLP certiﬁcate,
Mucedola, Milan, Italy); (ii) obesity-inducing diet, HFD (total 4.73 kcal g− 1—
carbohydrate 35%, fat 45% and protein 20%; diet #D12451, Research Diet,
New Brunswick, NJ, USA). HFD is commonly used to induce obesity.14,15
ND allows for comparisons both with the HFD animals, and also with data
obtained from our and other laboratories on the effect of CMS (which is
done in animals fed with ND).
Rats were kept undisturbed until they reached 13 weeks of age, and
thereafter each group (ND and HFD) was further randomly sub-divided
into two groups, one control (CON) and one exposed to CMS. The sample
size for all the experiments was of n= 11 for each CON group, n= 8 for
each CMS-ND group and n= 12 for each CMS-HFD group, except for the
corticosterone evaluation (n=6 CON-ND, n= 7 the rest of the groups;
corresponding to the number of animals for which serum was available).
The body weight (individual rat) and food intake (pair of rats of each cage)
of all animals were measured weekly over the course of the experiment.
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CON groups were handled for ~ 10min, 3 times per week, throughout the
experiment. Handlings were performed by holding each rat on the
experimenters’ arm or by allowing the rat to explore the environment
outside the cage, mainly on the bench around their cage. A battery of
behavioral tests (BT) was performed immediately after 6 weeks of exposure
to CMS. BTs were performed in the animals’ light phase and in the
following speciﬁc order, according to the sensitivity of the test, to avoid
potential between-test interference effects: elevated plus maze (EPM),
forced swimming test (FST) and Morris water maze (MWM).7,16 Experiments
were performed twice; and results are representative of one independent
experiment. All BTs and corticosterone level analysis were performed
blinded to the researcher. Figure 1 describes the experimental design and
the order of the BTs.
Chronic mild stress protocol
CMS is a series of unpredicted chronic mild stressors that intends to mimic
humans’ everyday life stressors.17 The protocol is a 6-week-long exposure
to unpredictable stressors (four stressors per day) including conﬁnement to
a restricted space (2 h), cage placement in a tilted cage (4 h), damp
bedding housing (12 h), overcrowding six males in a standard housing
cage (2 h), strobe light exposure (4 h), water deprivation for 12 h followed
by exposure to an empty bottle for 1 h and replacing bedding for cold tap
water (2 h). All stressors were imposed during the animal’s resting period
(light phase of the diurnal cycle), except the damp bedding housing, which
was done during the 12 h of the animal’s active period (dark phase of the
diurnal cycle).
Glucose tolerance test
Rats underwent i.p. glucose tolerance test (ipGTT) for insulin sensitivity
assessment at three different time points throughout the experiment:
before the start of CMS (week 0), in the middle of CMS (week 3) and at the
end of the CMS protocol (week 6). Rats were on food deprivation for 16 h
before the test, starting at the beginning of the dark phase of the light
cycle, at 2000 hours. An i.p. glucose (Merck Millipore, Darmstadt, Germany)
injection (2 g kg− 1 body weight) forced a rapid glucose challenge and the
glucose level in the blood was measured at time 0 (before the injection
(G0)) and at 20, 40, 60 and 120min post injection.18 Each time a drop of
blood was collected through a small puncture close to the tip of the rats’
tail, and the glucose level was determined by a glucose meter device (One
touch UltraMini, LifeScan, Madrid, Spain).
Forced swimming test
Depression-like behavior was determined by assessing the animal’s
learned helplessness behavior in the FST. Brieﬂy, 24 h after a pre-test
session (8 min), rats were individually placed in transparent containers
ﬁlled with water (25 °C) to a depth such that they had no solid support for
5 min. Recorded videos were later scored by an investigator blind to the
experimental groups. Learned helplessness behavior was deﬁned as the
amount of immobility time (deﬁned as the time spent either immobile or
making righting movements to stay aﬂoat).19
Elevated plus maze
Anxiety-like behavior was investigated by the EPM test. The apparatus is an
elevated (72.4 cm above the ﬂoor) plus shaped platform (ENV-560;
MedAssociates, St Albans, VT, USA) that contains two opposite open arms
(50.8 × 10.2 cm) and two closed arms (50.8 × 10.2 × 40.6 cm). Rats were
placed individually in the center of the apparatus and allowed to explore
the maze for 5 min while its ambulation was monitored online with an
infra-red photobeam system (MedPCIV, MedAssociates). The ratio of time
spent in the open arms versus in the close arms was considered an index
of anxiety-like behavior.
Morris water maze
Cognitive function was assessed by the animals’ performance in spatial
working, reference memory and reverse learning tasks in the MWM.20 The
MWM apparatus was a circular container (170 cm diameter; 50-cm deep)
ﬁlled with water (23 °C, around depth of 30 cm) in a dimly lit room. The
container was divided into imaginary quadrants with an extrinsic visual
clue for each, placed outside of the tank, and a small hidden platform
(submerged 2 cm below the surface of the water) placed in the center of
one of them. Data were collected using a video-tracking system
(Viewpoint, Champagne au Mont d’Or, France).
The spatial working memory task was performed in 4 sequential days
(four trials per day, maximum of 2min per trial). Test sessions started, in
each trial, by placing the rat in one of the imaginary quadrants (facing the
wall of the tank) and ended when the animal reached the platform or
when 2min had passed (thereafter the animal was gently guided to the
platform). Each trial corresponded to a different quadrant. The position of
the platform was changed on each day, such that after 4 days it had been
placed on all quadrants. The distance traveled to reach the platform
(escape latency) was evaluated.20,21 Immediately after the spatial working
task, animals were tested for spatial reference memory for additional
3 days with the platform remaining in the same quadrant as that of the last
day of the spatial memory task. This was to ensure that the animals
correctly learned the position of the platform before the reversal learning
task (further conﬁrmed in the probe test). The test was performed as
described above for the working memory task. After the last day of
reference memory evaluation, the platform was positioned in the quadrant
opposite to the previous one and rats performed the four-trial paradigm as
described above. Thereafter the platform was removed and the animal was
placed in the tank and allowed to search for the platform for 2 min. The
distance traveled in the quadrant containing the ﬁnal positioned platform
('target') versus the total distance traveled was calculated. In the water
maze paradigm, to evaluate working memory, the daily trial-to-trial
progression of the distance swum to reach the platform was averaged for
the different platform locations and, in the reference memory, day-to-day
progression was averaged across the four daily trials for the same platform
location.
Corticosterone determinations
To assess the glucocorticoid proﬁle, blood samples were collected from
each subject in two time points, namely light phase (0900–1000 hours) and
dark phase (2100–2200 hours). A few drops of blood were collected by
lancing the tip of the tail. The collected sera was stored at − 80 °C until
analysis. Blood collections were performed 5 days after the last BT was
completed to diminish any inﬂuence of the tests on the glucocorticoid
levels. Serum corticosterone levels were determined by radioimmunoassay
(MP Biochemicals, Costa Mesa, CA, USA).
Statistical analyses
Sample size determination was based on the main statistical procedures
used in this manuscript. For the different procedures a medium or high
effect size, a type I error α= 0.05 and a statistical power (type II error) of 0.8,
were considered. A total of 42 animals were used in each independent set
of experiments. Statistical test assumptions were validated for all the
analysis performed. Normality was assessed by Kolmogorov–Smirnov test
and conﬁrmed by the evaluation of skewness and kurtosis. The analysis
indicated that when normality was not accomplished all variables
presented absolute skewness and kurtosis below 1. This suggests that
the distribution was close to normal, thus parametric tests for statistical
Figure 1. Experimental timeline. Rats were sorted into two groups
with different diets, immediately after weaning until 13 weeks of
age and thereafter separated into 2 additional subgroups of CON
and CMS for each diet. Behavioral tests were performed, in the order
shown, immediately after the CMS protocol (6 weeks). All tests were
performed in the light phase of animals’ diurnal light cycle. Blood
was collected in the two light phases, 5 days after the last behavioral
test was performed. CMS, chronic mild stress; CON, control; EPM,
elevated plus maze; FST, forced swimming test; HFD, high-fat diet;
ipGTT, i.p. glucose tolerance test (at 3 time points); MWM, Morris
water maze; ND, normal diet.
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analysis were used. Sphericity assumption (for repeated measures) and
homogeneity of group variances were also veriﬁed and statistical
analyses were made accordingly. Multiple linear regression models (enter
method—all variables entering the regression model at the same time)
were used to identify the main predictors of body weight gain. Mixed-
design analysis of variance was used considering between (two factors:
diet and CMS) and within subject factors for weekly measurements of food
intake, distance swum in each trial in the spatial working task, distance
swum in each day in the reference memory performances in the MWM and
glucose level in each time point in the ipGTT. The data from the EPM, FST,
probe test of MWM, corticosterone levels and the different time points in
the diurnal circadian rhythm of food intake were analyzed by two-way
analysis of variance considering CMS and diet as between subject factors.
When there was an interaction effect between groups, it was decomposed
by splitting the samples according to either diet or CMS, and independent
samples t-test was performed. Outliers were excluded based on the
Z-score criteria Z4│3│. Results are expressed as group mean± s.e.m. and
statistical signiﬁcance was accepted for Po0.05 (two-sided). Statistical
analysis was performed using IBM SPSS statistics 20.0 (IBM, Armonk,
NY, USA).
RESULTS
CMS and HFD modulate body weight curves and feeding behavior
Weekly analyses of the body weight gain and calorie intake were
analyzed separately in two distinct periods: (i) exposure to
different diets to the beginning of CMS (4–13 weeks of age);
and (ii) during CMS (14–21 weeks of age). In the ﬁrst step of the
analysis, multiple linear regression models were used to explore
the diet effect on body weight at the week 13, controlling for
initial weight (week 4). Thereafter, body weight at week 21 of age
was considered as the dependent variable, while diet, stress and
body weight in the week 13 were considered as predictors.
Multiple linear regression analysis of the ﬁrst period was
statistically signiﬁcant (F(2,39) = 26.91; Po0.001), indicating that
56% (R2 = 0.58; R2Adj = 0.56) of the body weight at week 13 was
explained by diet (β= 0.77; Po0.001) and by initial body weight
(β= 0.19; P= 0.08). The regression analysis was also signiﬁcant at
21 weeks (F(3,38) = 61.66; Po0.001), showing that 82% (R2 = 0.83;
R2Adj = 0.82) of the body weight at week 21 was signiﬁcantly
explained by stress (β=− 0.30; Po0.001), body weight (β= 0.65;
Po0.001) and diet (β= 0.23; P= 0.038) on week 13 (Figure 2). This
indicates that after controlling for diet and body weight on week
13, stress has a signiﬁcant effect on body weight at week 21.
Statistical analysis for daily food consumption (in kcal) was also
separated in the same two analysis steps previously described
(Figure 3a). The ﬁrst analysis indicated that groups fed with HFD
consumed higher amounts of kcal compared with the ND group
(F(1,12) = 36.2; Po0.001), a pattern that remained unaltered in the
second phase (F(1,8) = 26.6; P= 0.001) regardless of exposure to
CMS. However, in both CMS groups a remarkable drop in the
amount of energy intake in the ﬁrst 3 weeks of the CMS protocol
when compared with their CON group (CMS effect on, week 14:
F(1,14) = 21.6; Po0.001; week 15: F(1,15) = 9.98; P= 0.006; week 16:
F(1,15) = 35.84; Po0.001) was noted. This reduction disappeared
after the third week, as the energy intake reached the control level
by the fourth week of CMS. Nevertheless, there was a CMS
(F(1,16) = 9.49; P= 0.007) and diet (F(1,16) = 56.4; Po0.0001) effect in
the total amount of energy consumed during the 6 weeks of CMS.
Further analysis when the CMS effect was considered indepen-
dently of the diet, indicated that energy intake of the CMS-HFD
group was signiﬁcantly lower than that of the CON-HFD group
(t(9) = 2.9; P= 0.02), a ﬁnding that was not seen in the CMS-ND
versus CON-ND groups (t(7) = 1.53; P= 0.17) (Figure 3b).
In addition, data from food intake in separate light phases
indicated a circadian rhythm in the CON groups with a higher
amount of consumption during the activity period (dark phase)
compared with the resting period (light phase). This circadian
pattern was remarkably ﬂattened in both stressed groups, which
led to an equally distributed amount of energy intake throughout
the diurnal cycle (Figure 3c) (diet effect: in dark phases,
(F(1,10) = 9.1; P= 0.01) and (F(1,10) = 9.9; P= 0.01), respectively; in
light phases, (F(1,11) = 1.66; P= 0.22) and (F(1,11) = 6.3; P= 0.03),
respectively. CMS effect: in dark phases, (F(1,10) = 11.2; P= 0.01) and
(F(1,10) = 7.8; P= 0.02), respectively; in light phases, (F(1,11) = 10.47;
P= 0.01) and (F(1,11) = 15.68; P= 0.002), respectively).
HFD and CMS induce glucose intolerance
ipGTT was performed in three time points during the CMS
protocol (Figure 4). Glucose levels 20 min after glucose injection
(G20) displayed an increase in all groups, as expected. However,
there was a glucose tolerance impairment in the HFD groups, with
a signiﬁcant diet effect between groups in all time points: week 0
of CMS (F(1,40) = 33.07; Po0.001) (Figure 4a); week 3 of CMS
(F(1,36) = 22.47; Po0.001) (Figure 4b); and, week 6 of CMS
(F(1,37) = 25.23; Po0.001) (Figure 4c). Furthermore, within ND
group, CMS animals presented a higher peak compared with the
CON group at G20 at the end of week 6 of CMS (t(14) =− 2.22;
P= 0.043). This impairment was not observed in the HFD group,
probably due to the ceiling effect of the diet in this time point.
Interestingly, the impairment noted in the CMS-ND group was not
yet present at week 3 of CMS.
Corticosterone serum levels are disrupted by CMS and HFD
Glucocorticoid data showed an interaction effect in the cortico-
sterone levels (F(1,23) = 4.7; P= 0.04) when the blood sample was
collected in the light phase; however, no CMS or diet effect was
noted between groups. These data indicates that CMS-ND had
signiﬁcantly higher glucocorticoid levels compared with their CON
group (t(10,7) =− 2.6; P= 0.025). On the other hand, in the HFD
groups no statistical signiﬁcant difference was observed between
HFD-CON and HFD-CMS groups (t(11,12) =− 0.9; P= 0.4). Data from
the dark phase displayed an interaction (F(1,22) = 8.4; P= 0.008) and
a diet effect (F(1,22) = 4.6; P= 0.043) in between groups. Additional
analysis revealed a similar result, namely signiﬁcantly different
glucocorticoid levels in the ND group (t(10) =− 2.5; P= 0.048) but
not in the HFD group (t(12) = 1.7; P= 0.11). CON-HFD animals
Figure 2. Body weight gain throughout the experiment. (n= 11 each
control group, n= 8 CMS-ND group, n= 12 CMS-HFD group; *** and
###: Po0.001. Data presented as mean± s.e.m.). *** Shows diet
effect and ### indicates CMS effect. CMS, chronic mild stress;
HFD, high-fat diet; ND, normal diet.
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display increased corticosterone levels when compared with the
CON-ND animals (t(11) =− 2.7; P= 0.02) (Figure 4d). Also of notice,
CON-ND display the expected increase in the corticosterone levels
in the dark phase when compared with those in the light phase
(t(5) =− 4.54; P= 0.006), an effect that was blunted in the CON-HFD
group (t(6) = 0.1; P= 0.93).
CMS and HFD alter emotional and cognitive behaviors
FST data showed that both diet (F(1,27) = 11.1; P= 0.003) and CMS
(F(1,27) = 12.56; P= 0.001) had an overall effect on immobility time
(Figure 5a), indicating a signiﬁcantly increased immobility time
in animals exposed to a HFD, and CMS when compared with
CON-ND.
EPM data indicated no remarkable effect of diet or of CMS on
anxiety-like behavior. On the other hand, an interaction effect
between diet and CMS was observed in all groups, showing that
animals with HFD and CMS spent less time in the open arms when
compared with the CON-ND (F(1,36) = 4.6; P= 0.039) (Figure 5b).
Further analysis also indicated that CON-HFD spent signiﬁcantly
less time in the open arms compared with CON-ND (t(18) = 2.65;
P= 0.02). In addition, the number of total entries in the closed
arms, which is an index of locomotor activity, was similar in all
groups (diet effect: (F(1,34) = 1.1; P= 0.31); CMS effect: (F(1,34) = 0.1;
P= 0.72)) (Figure 5c).
The learning curve in the MWM task was not different between
groups, both for the spatial working (diet effect: (F(1,34) = 3.08;
P= 0.09); CMS effect: (F(1,34) = 1.38; P= 0.25)) (Figure 5d) and
Figure 3. Food consumption measurements (ϕ, *: Po0.05; ϕϕ, ##, and αα: Po0.01; ***: Po0.0001. * and # indicate the overall effect of diet and
CMS, respectively). Data presented as mean± s.e.m. All the measurements are shown as kcal consumption per animal. (a) Energy intake by
kcal per day throughout the experiment. (n= 5 cages for each CON group, n= 4 cages CMS-ND group, n= 6 cages CMS-HFD group). * and
*** present CMS and diet overall effect, respectively. Statistically signiﬁcant differences between CON and CMS groups are shown by ϕ, ϕϕ for
ND and αα for HFD. (b) Total kcal intake during the 6 weeks of CMS. (c) Food consumption evaluation in separate phases of the diurnal
circadian rhythm, measurements were assessed at the time of phase change (0800 and 2000 hours) (n= 4 cages for each group); * and ##
indicate the overall effect of diet and CMS, respectively. CMS, chronic mild stress; CON, control; HFD, high-fat diet; ND, normal diet.
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Figure 4. Glucose tolerance test (GTT) and corticosterone levels. (a) GTT in week 0 (before the start of CMS), (b) GTT in week 3 (half way
through CMS), (c) GTT in week 6 (at the end of CMS). ** presents the statistically signiﬁcant diet overall effect between groups. ϕ indicates the
statistically signiﬁcant increase of glucose level in the CMS-ND when compared with CON-ND. (n= 11 each control group, n= 8 CMS-ND
group, n= 12 CMS-HFD group; * and ϕ: Po0.05 and **: Po0.01. Data presented as mean± s.e.m.) (d) Corticosterone levels in the light
(0900 hours) and dark (2100 hours) phases of diurnal light cycle after 6 weeks of CMS protocol. Data illustrate an interaction effect in both
light- and dark-phases corticosterone levels. ϕ indicates the statistically higher level of corticosterone in CMS-ND group when compared with
CON-ND group. * indicates the statistically higher level of corticosterone in CON-HFD group when compared with CON-ND group. (n= 6 for
each group; * and ϕ: Po0.05. Data presented as mean± s.e.m.). CMS, chronic mild stress; CON, control; HFD, high-fat diet; ND, normal diet.
Figure 5. Behavioral assessment. (a) Forced swimming test (FST). Learned helplessness assessment by the time of immobility in the 5min of
testing. (b) Elevated plus maze (EPM). Anxiety-like behavior evaluation by the time spent in the open arms. There is an interaction effect
between diet and CMS between groups. (c) EPM. Number on entries in the open arms indicate the locomotor activity. (d) Spatial working task.
Each trial shows the average of the distance swum to reach the platform in the same trial in all 4 days of the test, which illustrates the learning
progression. (e) Reference memory. Each day indicates the average distance swum in the 4 trials of the same day to evaluate the speed in
learning the position of the platform. (f) Probe test. Distance swum in the quadrant of the new positioned platform after the reference
memory task indicates the animal’s behavioral ﬂexibility. For all the ﬁgures (n= 11 each control group, n= 8 CMS-ND group, n= 12 CMS-HFD
group; *: Po0.05; ** and ##: Po0.01. Data presented as mean± s.e.m.). * and ** indicate diet and, ## indicates CMS overall effects between
groups. CMS, chronic mild stress; HFD, high-fat diet; ND, normal diet.
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reference memories (diet effect: (F(1,36) = 3.59; P= 0.07); CMS effect:
(F(1,36) = 0.08; P= 0.78)) (Figure 5e). However, the probe test
showed that diet had a signiﬁcant overall effect on the distance
swum in the target quadrant (F(1,35) = 4.31; P= 0.045) (CMS effect:
(F(1,35) = 1.28; P= 0.26)), with animals on HFD swimming a smaller
distance in the 'target' quadrant when compared with their
corresponding ND group (Figure 5f).
DISCUSSION
Summarily, in this study we showed that HFD consumption,
besides leading to obesity as expected,14 altered the animals’
behavioral state by promoting depressive- and anxiety-like
behaviors. The diet-induced body weight increase was particularly
evident by the end of the experiment (5 months of age), with the
CON-HFD animals weighting 30% more than the CON-ND. A
delayed body weight gain of animals on ND is a well-known effect
of the CMS protocol.13,22–24 Interestingly, exposure to CMS did not
further aggravate the HFD-induced behavioral changes, while
stress reduced the amount of daily food consumption; regardless
of the type of diet this reduction was only observed in the ﬁrst
3 weeks of exposure to CMS. The initial immediate decrease of
food intake observed on CMS exposure is identical to that
reported on previous studies on acute restraint stress,25 but here it
is also now reported that 3 weeks after the CMS protocol, animals
recover their normal pattern on energy consumption.
Of note, both in CMS-ND and in CMS-HFD the body weight gain
was reduced when compared with that of the CON group.
Furthermore, despite of similar trends, the total amount of energy
intake in the 6 weeks of the CMS period was signiﬁcantly smaller
in the CMS group fed by HFD when compared with the CON-HFD;
an alteration that was not observed in the ND group (CMS-ND
versus CON-ND). These interesting ﬁndings suggest that the CMS-
HFD group lost weight due to a reduction in energy intake during
the extension of the protocol, while in the CMS-ND group other
factors probably underlie the reduction in the body weight gain.
These factors may include different metabolic and hormonal
milieu of normal, obese and stress-exposed individuals. In fact,
several publications have reported the deleterious impact of
obesity and of stress in feeding habits, blood and brain
inﬂammation, and in neurodegeneration.1,26 For instance, white-
adipose tissue itself produces adipokines,27 interleukins and leptin
(an adipokine regulating food intake through dopamine
pathway).28 Hence, high levels of white-adipose tissue will secrete
higher levels of adipokines directly modulating feeding habits and
the inﬂammatory proﬁle. This is potentiated in animals with
obesity due to the hyperplasia and hypertrophy of their
adipocytes.29 On the other hand, stressful events can also trigger
an inﬂammatory proﬁle, since higher levels of corticosteroids and
catecholamines can potentiate the production of cytokines in a
similar manner to an inﬂammatory state, exerting a direct impact
on behavior.30
Another interesting observation relates to the circadian rhythm
of food consumption: rats normally consume remarkably more
(peak) during their active period (dark phase) compared with the
resting period. Here, this pattern was inverted in both CMS groups
(increased food intake in the light-period and decreased in the
dark phases of the daily light cycle). We have previously found
that exposure to CMS in the light phase leads to forced awakening
and circadian rhythm disruption.31 In accordance, forced activity
in the light phase appears to modify the temporal pattern
of food intake, potentially leading to a misalignment of metabolic
function with the biological clock, the so-called internal
desynchronization.32–34 Along with other complications, internal
desynchronization causes behavioral instability, sleep disturbance
and dampening of metabolic and endocrine diurnal rhythms.
These, in the long-term, can lead to many disorders, such as
metabolic syndrome and depression.35,36
As a measure of metabolic alterations, ipGTT was used. Injection
of glucose to fasted animals should cause a sudden rise of the
serum glucose levels in G20, which then declines to the baseline
values in ~ 2 h.37 Here, we observed a signiﬁcant impaired glucose
tolerance in the HFD groups in all three periods assessed. These
data are in accordance with previous reports, indicating metabolic
alterations in HFD-fed subjects, such as type 2 diabetes and insulin
resistance.14,37,38 Interestingly, glucose tolerance impairment in
the CMS-ND group occurred only at the end of the stress protocol,
and not at week 3. This reveals that the metabolic alterations were
only developed after the daily food intake recovery, suggesting
the impact of the body’s distinct coping strategies on metabolism
during the exposure to chronic stress, such as energy expenditure
acceleration, that also leads to body weight reduction. In the HFD
group, on the other hand, no further increase in glucose
concentration was observed in the CMS group, which may be
due to the ceiling effect induced by the HFD.
Furthermore, glucocorticoids, which are activated through the
hypothalamic–pituitary–adrenal axis, are known modulators of
energy homeostasis,2,39 and hypothalamic–pituitary–adrenal axis
over-activation has been shown to alter insulin action resulting in
'insulin resistance'.39 Accordingly, the present data showed that
the CMS-ND group had signiﬁcantly higher levels of glucocorticoid
in both the light and dark phases of the diurnal cycle. Of notice,
the HFD group displayed higher basal glucocorticoid levels, as
previously reported,2,40 which were not further elevated by CMS.
In addition, when compared with the CON-ND, the CON-HFD
group had increased corticosteroid levels in the light phase of the
diurnal cycle, the time of the day in which the behavior tests
were performed; thus diet alone is associated to an hormonal
pattern that may underlie the observed behavior differences as
will next be discussed.
Stress, especially when driven by CMS protocols, has a known
impact on emotional behavior.41 Mood was assessed by the FST,
which measures behavioral despair (learned helplessness).7,19,41
Importantly, this test was performed and not the sucrose-
preference test (that measures anhedonia) as the animals were
under distinct diets with different tastes and caloric value, which
may have an impact on the animals food preferences. Here,
regardless of body weight, a CMS overall effect in the immobility
time was observed, as it has been demonstrated before.41,42 Of
notice, CON-HFD had an immobility time equal to that of the CMS-
ND group, indicating a depressive-like behavior. Again of interest,
exposure to CMS did not further increase the immobility time
already observed in the CON-HFD group. In accordance, a direct
effect of obesity on mood disorders, namely in depression, has
been described in the literature,43–45 although there are some
conﬂicting observations.3,4,46 A recent report on the effect of
antidepressants in mice under a HFD and exposed to a stress
protocol showed that mice fed with HFD (for 14 weeks) and
exposed to CMS protocol (for 4 weeks) had a decreased body
weight and increased immobility time in the FST. This result
supports a potentiation of the depressive-like behavior in the
CMS-HFD when compared with the CON-HFD group.15 Of notice,
HFD rats in the present study showed a resistance to further
increase the depressive-like phenotype in response to CMS. This
can be due to the fact that animals were fed with HFD for a
4-week longer period before application of the CMS protocol, which
may have more pronounced impact on the animals’ behavioral
alteration in response to the stressors. Moreover, here rats rather
than mice were used, and it is known that these species may
display different behavioral proﬁles. Still, both studies revealed a
depressive-like behavior outcome of animals under HFD. While the
increased corticosteroid levels induced by HFD may contribute to
the behavioral changes observed, additional research is necessary
to understand the precise mechanisms of the effect of diet-
induced obesity on the response to environmental stressors,
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especially given the known role of orexigenic and anorexigenic
peptides in mood behavior.25,47
Stress is also known to trigger anxiety,16,41,42 which was also
observed here given the decrease in the time spent by stressed
animals in the open arm of the EPM, regardless of the animals’
body weight. Animals fed with HFD also presented anxiety-like
behavior when compared with those on ND, which is in
accordance with observations reported in another study of diet-
induced obese mice.38 Although there are inter-species differ-
ences between these studies, it is interesting that similar
evidences are found in some behavioral dimensions. Moreover,
the number of entries in the closed arms indicated that the CON-
HFD group did not have compromised locomotor or exploratory
abilities in this test. Interestingly, again, CMS did not further
aggravate the anxiety-like behavior displayed by the CON-HFD
group. These ﬁndings are in accordance with the glucocorticoid
data, whose levels do not further increase in the HFD by the CMS.
With respect to the effect of CMS and HFD on cognition, no
spatial learning or reference memory impairments were detected,
which is in line with some previous observations.31,41 However,
some studies have found correlations between memory and
learning impairments with other types of stress7,16,20,48,49 and with
obesity.50,51 Still, the present data reveals a remarkable diet effect
in the distance swum in the target quadrant in the probe test,
indicating disturbed behavioral ﬂexibility in the animals fed
by HFD.
In summary, the present study shows the interplay between
HFD and chronic stress in different behavioral end-points,
highlighting that animals with different metabolic and mood
states respond differently to chronic exposure to mild stressors.
This is a signiﬁcant ﬁnding largely neglected in the ﬁeld. Even
though this is a descriptive study, and thus the underlying
mechanisms need to be further explored, the data presented
herein are of relevance particularly in the context of the current
obesity epidemic, and indicates that HFD impacts on the response
to CMS, which should be considered when addressing the
consequences of obesity on behavior.
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